We are live on ! Find out more
VXRT

Vaxart
VXRT

Delisted

VXRT was delisted on the 7th of July, 2025.

Back to rankings

34 hedge funds and large institutions have $6.64M invested in Vaxart in 2017 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 7 increasing their positions, 3 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

133% more repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 3

100% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 3

8% more capital invested

Capital invested by funds: $6.17M → $6.64M (+$467K)

6% more funds holding

Funds holding: 32 → 34 (+2)

0.11% more ownership

Funds ownership: 2.17% → 2.28% (+0.11%)

Holders
34
Holders Change
+2
Holders Change %
+6.25%
% of All Funds
0.85%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
7
Reduced
3
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
AC
Armistice Capital
New York
+$158K
2
Renaissance Technologies
Renaissance Technologies
New York
+$83.7K
3
WT
Wellcome Trust
United Kingdom
+$78.8K
4
OMC
Oasis Management Company
Cayman Islands
+$66.6K
5
VF
Virtu Financial
New York
+$57.6K

Top Sellers

Rank Fund Capital Flow
1
TRCT
Tower Research Capital (TRC)
New York
-$33K
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$15.3K
3
UBS Group
UBS Group
Switzerland
-$10.7K
4
Morgan Stanley
Morgan Stanley
New York
-$170
Name Holding Trade Value Shares
Change 		Change in
Stake
RJFSA
26
Raymond James Financial Services Advisors
Florida
$10K +$1.24K +182 +16%
Morgan Stanley
27
Morgan Stanley
New York
$6K -$170 -25 -3%
AG
28
Advisor Group
Arizona
$3K – – –
Group One Trading
29
Group One Trading
Illinois
$1K – – –
TRCT
30
Tower Research Capital (TRC)
New York
– -$33K -4,471 Closed
UBS Group
31
UBS Group
Switzerland
– -$10.7K -1,580 -99%
Royal Bank of Canada
32
Royal Bank of Canada
Ontario, Canada
– +$20 +3 New
1
2

VXRT Hedge Fund Activity: Q3 2017 in Review

34 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Vaxart (VXRT) for Q3 2017, worth a combined $6.64M — up 7.6% from $6.17M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new VXRT positions and 3 closed out — a net gain of 3 holders — while 7 added to existing stakes and 3 trimmed.

The largest buyer was Armistice Capital, adding an estimated $158K. The largest seller was Tower Research Capital (TRC), exiting entirely with an estimated $33K sold.

  • 34 institutional investors held Vaxart (VXRT) as of Q3 2017, up from 32 in Q2 2017.
  • Funds reported $6.64M of Vaxart stock for Q3 2017, up 7.6% quarter-over-quarter.
  • 6 funds opened new Vaxart positions in Q3 2017 and 3 closed out, a net change of +3 holders.
  • The largest Vaxart buyer in Q3 2017 was Armistice Capital, an estimated $158K added.
  • The largest Vaxart seller in Q3 2017 was Tower Research Capital (TRC), an estimated $33K sold.

Based on aggregated 13F filings for Q3 2017.